Past competitions
Since its launch in 2018, the ADLM Disruptive Technology Award has recognized breakthrough diagnostics from many innovative companies.
2025
Winner: Rarity Bioscience
Finalists: Chemeleon and MagIC Lifescience
Semifinalists: BloodScan Biotech Inc, C2N Diagnostics, and Truvian
2024
Winner: Mercy BioAnalytics
Finalists: Dionysus Digital Health and Vitestro
Semifinalists: Babson Diagnostics, Meliolabs, and PBD Biotech
2023
Winner: Pattern Bioscience
Finalists: MS Pen Technologies, Inc. and Vital Biosciences Inc.
Semifinalists: Cardio Diagnostics Holdings, Inc, Eximius Diagnostics Corporation, and Micronoma
2022
Winner: Nanopath
Finalists: Biological Dynamics, Inc. and Visby Medical
Semifinalists: Co-Diagnostics, Inc., Cytovale Inc., and FloBio LLC
2021
Winner: Day Zero Diagnostics, Inc.
Finalists: Mammoth Biosciences and MeMed
Semifinalists: numares GROUP Corporation, OncoHost, and Sight Diagnostics
2020
Winner: Baebies, Inc
Finalists: Alcediag and Sherlock Biosciences
Semifinalists: Cardea Bio, Geneoscopy, and Zepto Life Technology
2019
Winner: Inflammatix
Finalists: PixCell Medical and Singlera Genomics
Semifinalists: Bacteromic, COMBiNATi, Newomics, and PCR ONE
2018
Winner: GNA Biosolutions
Finalists: Ativa Medical and Two Pore Guys
Semifinalists: Brevitest, Druley Lab, miDiagnostics, and PROMISE